Kearns, L., Chapman, C. R., Moch, K. I., Caplan, A. L., Watson, T., McFadyen, A., . . . Bateman-House, A. (2021). Gene therapy companies have an ethical obligation to develop expanded access policies. Mol Ther.

Kearns, Lisa, Carolyn Riley Chapman, Kenneth I. Moch, Arthur L. Caplan, Tom Watson, Andrew McFadyen, Pat Furlong, e Alison Bateman-House. "Gene Therapy Companies Have an Ethical Obligation to Develop Expanded Access Policies." Mol Ther 2021.

Kearns, Lisa, et al. "Gene Therapy Companies Have an Ethical Obligation to Develop Expanded Access Policies." Mol Ther 2021.